MedPath

ANTICOAGULANT CITRATE DEXTROSE SOLUTION USP (ACD) FORMULA A

ANTICOAGULANT CITRATE DEXTROSE SOLUTION USP (ACD) FORMULA A

Approved
DIN Number

02469731

Drug Class

Human

Market Date

Jun 20, 2018

Company
HC

TERUMO BCT, INC.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02469731
AIG Number0359691001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Ethical
A
ATC Code
V07AC BLOOD TRANSFUSION, AUXILIARY PRODUCTS
Product Specifications
Dosage FormSolution
Route of Administration0-Unassigned
AHFS Classification20:12.04.92
Health Canada Classification

ACTIVE INGREDIENTS (3)

CITRIC ACID MONOHYDRATEActive
Strength: 0.8 G / 100 ML
Monograph: CITRIC ACID MONOHYDRATE
DEXTROSEActive
Strength: 2.45 G / 100 ML
Monograph: DEXTROSE
SODIUM CITRATE DIHYDRATEActive
Strength: 2.2 G / 100 ML
Monograph: SODIUM CITRATE DIHYDRATE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.